肺癌的支气管成形手术：136例患者的临床研究
Bronchoplastic procedures for lung cancer: clinical study in 136 patients.
作者信息
Kawahara K, Akamine S, Tsuji H, Nakamura A, Takahashi T, Tagawa Y, Ayabe H, Tomita M
机构信息
First Department of Surgery, Nagasaki University School of Medicine, Japan.
出版信息
World J Surg. 1994 Nov-Dec;18(6):822-5; discussion 825-6. doi: 10.1007/BF00299075.
Between 1969 and 1991 a total of 136 patients (119 men, 17 women) underwent bronchoplastic procedures for lung cancer. A bronchoplastic procedure with angioplasty was performed in 37 patients. Ages ranged from 30 to 79 years (mean 62 years). The histologic type of cancer was squamous cell carcinoma in 97 patients (70.0%). The 30-day mortality was 5.1% (7 patients), and morbidity was 30.1% (41 patients). The most common complications were bronchopleural fistula in nine (6.6%), stricture or stenosis in eight (5.9%) and atelectasis in eight patients. Local recurrence occurred in nine (6.6%) patients. The overall 5-year survival for patients undergoing bronchoplastic procedures was 37.1%: 60.1% for patients with stage I disease (n = 41), 31.7% for stage II (n = 17), and 29.7% for stage IIIA (n = 66). We conclude that bronchoplastic procedures are effective therapy for selected patients with lung cancer.
1969年至1991年间，共有136例患者（119名男性，17名女性）接受了肺癌支气管成形手术。37例患者进行了支气管成形术联合血管成形术。年龄范围为30至79岁（平均62岁）。97例患者（70.0%）的癌症组织学类型为鳞状细胞癌。30天死亡率为5.1%（7例患者），发病率为30.1%（41例患者）。最常见的并发症是支气管胸膜瘘9例（6.6%）、狭窄8例（5.9%）和肺不张8例。9例（6.6%）患者出现局部复发。接受支气管成形手术患者的总体5年生存率为37.1%：I期疾病患者（n = 41）为60.1%，II期患者（n = 17）为31.7%，IIIA期患者（n = 66）为29.7%。我们得出结论，支气管成形手术是治疗特定肺癌患者的有效方法。
Zotero 插件